Publications by authors named "R Hamacher"

Claim this Profile
R
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial.
Christoph E Heilig, Christoph Heining, Editha Gnutzmann, Sandra Roldan, Laura Heiligenthal, Rainer Hamacher

Cancer Treat Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ga]Ga-FAPI-46 PET/CT of Patients with Gastrointestinal Stromal Tumors in Comparison to 2-[F]FDG PET/CT and Contrast-Enhanced CT: Results from a Prospective Observational Study.
Timo Bartel, Kim M Pabst, Christina Barg, Christoph A Berliner, Rainer Hamacher

J Nucl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial).
Johanna Falkenhorst, Philipp Ivanyi, Tom Schulz, Rainer Hamacher, Bernd Kasper

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Y-FAPI-46 Theranostics Leads to Near-Complete Metabolic Response in 3 Patients with Solitary Fibrous Tumors.
Helena Lanzafame, Christoph E Heilig, Eva Wardelmann, Mélanie Desaulniers, Kim Magaly Pabst, Rainer Hamacher

J Nucl Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ga]Ga-FAPI-46 PET accuracy for cancer imaging with histopathology validation: a single-centre, single-arm, interventional, phase 2 trial.
Kim M Pabst, Manuel M Weber, Christina Laschinsky, Patrick Sandach, Timo Bartel, Rainer Hamacher

Lancet Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis